CRISPR-based gene-editing tools are being developed to correct specific defective sections of the genome to cure inherited genetic diseases, with some applications already in clinical trials. However, ...

The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

The CRISPR molecular scissors have the potential to revolutionize the treatment of genetic diseases. This is because they can be used to correct specific defective sections of the genome.

The executive director of the nonprofit patient advocacy group the Sickle Cell Consortium was diagnosed with sickle cell disease ... that uses genetic modification called CRISPR.

The CRISPR tool is capable of repairing the genetic defect responsible for the immune disease chronic granulomatous disease. However, researchers at the University of Zurich have now shown that ...

PRNewswire/ -- "According to the latest study from BCC Research, the demand for Gene Editing Therapeutics is estimated at $11 ...

As well as breathlessness and fatigue, the disease often causes numbness in the hands and can lead to patients feeling dizzy ...

Around the beginning of the year, two new breakthrough gene editing medications — including the first FDA-approved CRISPR-based drug ... considered a functional cure in the field.

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...